A method of treating allergic disorders and pharmaceutical compositions therefore are disclosed for a series of 5-[(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives of Formula I. These compounds are useful in inhibiting Type I allergic ##STR1## responses in a living animal and thus can be used to treat allergic phenomena such as asthma, rhinitis, atopic dermatitis, chronic hives, allergic conjunctivitis and the like.
揭示了一种治疗过敏性疾病的方法和药物组合物,用于一系列Formula I的5-[(4-芳基-1-
哌嗪基)烷基]-
2-噁唑烷酮衍
生物。这些化合物在抑制活体动物中的I型过敏##STR1##反应方面很有用,因此可用于治疗哮喘、鼻炎、特应性皮炎、慢性荨麻疹、过敏性结膜炎等过敏现象。